Intermediate or chronic cutaneous leishmaniasis: Leukocyte immunophenotypes and cytokine characterisation of the lesion

Experimental Dermatology

Volumn 11, Issue 1, 2002, Pages 34-41

  Diaz, N L ^a   Zerpa, O ^a   Ponce, L V ^a   Convit, J ^a   Rondon, A J ^a   Tapia, F J ^a  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

Author keywords

Chronic cutaneous leishmaniasis; Cutaneous leukocyte antigen; Cytokine pattern; Intermediate leishmaniasis; Leukocyte immunophenotypes

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; CUTANEOUS LYMPHOCYTE ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; LYMPHOCYTE ANTIGEN; T6 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; CTAGE1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL DENSITY; CHRONIC DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EPIDERMIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LANGERHANS CELL; LEISHMANIA BRAZILIENSIS; LEISHMANIA MEXICANA; LEUKOCYTE; LYMPHOCYTE COUNT; PHENOTYPE; PRIMED LYMPHOCYTE TYPING; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SKIN BIOPSY; SKIN LEISHMANIASIS; STAGING; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANTIGENS, CD; ANTIGENS, NEOPLASM; CHRONIC DISEASE; CYTOKINES; HUMANS; IMMUNOPHENOTYPING; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, DIFFUSE CUTANEOUS; LEISHMANIASIS, MUCOCUTANEOUS; LEUKOCYTES; MEMBRANE GLYCOPROTEINS;

EID: 0036484347     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2002.110104.x     Document Type: Article

References (25)

1. Convit J, Pinardi M E, Rondón A J. Diffuse cutaneous leishmaniasis: A disease due to an immunological defect of the host. Trans R Soc Trop Med Hyg 1972: 66: 603-610.
2. Convit J. Leprosy and leishmaniasis. Similar clinical immunological pathological models. Ethiop Med J 1974: 12: 187-195.
3. Convit J, Castellanos P L, Ulrich M et al. Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis. J Infect Dis 1989: 160: 104-115.
4. Halmai-Stupar O, Arosemena-Sarkissian R, Paez E, Weiss E, Rondon A. American cutaneous leishmaniasis: Intermediate form. Int Dermatol 1993; 32: 204-205.
5. Convit J, Ulrich M, Fernandez C T, et al. The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1993: 87: 444-448.
6. Tapia F J, Cáceres-Dittmar G, Sánchez M A. Inadequate epidermal homing leads to tissue damage in human cutaneous leishmaniasis. Immunol Today 1994: 15: 160-165.
7. Tapia F J, Cáceres-Dittmar G, Sánchez M A, Fernández C T, Rondón A J, Convit J. Adhesion molecules in lesions of American cutaneous leishmaniasis. Exp Dermatol 1994: 3: 17-22.
8. Tapia F J, Cáceres-Dittmar G, Sánchez M A. Epidermal immune privilege in American cutaneous leishmaniasis. In: Tapia, F J, Cáceres-Dittmar, G, Sánchez, M A, eds. Molecular and Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis. Austin: R.G. Landes Co. Bioscience Publishers 1996, 139-152.
9. Rodríguez N, Aguilar C M, Barrios M A, Barker D C. Detection of Leishmania braziliensis in naturally infected individual sandflies by the polymerase chain reaction. Trans R Soc Trop Med Hyg 1999: 93: 47-49.
10. Hofmann F M, Billing R J, Parker J W, Taylor C R. Cytoplasmic as opposed to surface Ia antigen expressed on human peripheral blood lymphocytes and monocytes. Clin Exp Immunol 1982: 49: 355-363.
11. Gross A, Weiss E, Tapia F J, Aranzazu N, Gallinoto M E, Convit J. Leukocyte subsets in the granulomatous response produced after inoculation with Mycobacterium leprae - BCG in lepromatous patients. Am J Trop Med Hyg 1988: 38: 608-612.
12. Tapia F J, Rojas E, Kraal G et al. Immunocytochemical analysis of Langerhans cells in murine cutaneous leishmaniasis. In: 'The Langerhans Cells', Thivolet J, Schmitt D, eds. John Libbey Eurotext Ltd., London, United Kingdom 1988: 479-489.
13. Martínez-Arends A, Tapia F J, Cáceres-Dittmar G, Mosca W, Valecillos L, Convit J. Immunocytochemical characterization of immune cells in lesions of American cutaneous leishmaniasis using novel T cell markers. Acta Trop 1991: 49: 271-280.
14. Zerpa O, Díaz N L, Cabrera M et al. Leishmaniasis cutánea intermedia: Aspectos Clínicos, inmunológicos y parasitológicos. XIV Ibero Latin American Congress of Dermatology, Malaga, Spain, June 1999.
15. Weigle K, Saravia N G. Natural history, clinical evolution, and the host-parasite interaction in New World cutaneous leishmaniasis. Clin Dermatol 1996: 14: 433-450.
16. Katou F, Ohtani H, Saaristo A, Nagura H, Motegi K. Immunological activation of dermal Langerhans cells in contact with lymphocytes in model of human inflamed skin. Am J Pathol 2000: 156: 519-527.
17. Chen S, Akbar S M, Tanimoto K et al. Absence of CD83-+ mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: Relevance to hepatocarcinogenesis. Cancer Lett 2000: 148: 49-57.
18. Koszik F, Strunk D, Simonitsch I, Picker L J, Stingl G, Payer E. Expression of monoclonal antibody HECA-452-defined E-selectin ligands on Langerhans cells in normal and diseased skin. J Invest Dermatol 1994: 102: 773-780.
19. Teraki Y, Picker L J. Independent regulation of cutaneous lymphocyte-associated antigen expression and cytokine synthesis phenotype during human CD4+ memory T cell differentiation. J Immunol 1997: 159: 6018-6029.
20. Larsen C P, Steinman R M, Witmer-Pack M, Hankins D F, Morris P J, Austyn J M. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990: 172: 1483-1493.
21. Pope M, Betjes M G, Hirmand H, Hoffman L, Steinman R M. Both dendritic cells and memory T lymphocytes emigrate from organ cultures of human skin and form dinstinctive dendritic-T-cell conjugates. J Invest Dermatol 1995: 104: 11-17.
22. Cáceres-Dittmar G, Tapia F J, Sánchez M A et al. Determination of the cytokine profile in American cutaneous leishmaniasias using the polymerase chain reaction. Clin Exp Immunol 1993: 91: 500-505.
23. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceiçao-Silva F, Modlin R L. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 1993: 91: 1390-1395.
24. Castés M. Th1 and Th2 responses in human cutaneous leishmaniasias: Relation to the outcome of infection and implications for immunotherapy and vaccine development. In: Tapia F J, Cáceres-Dittmar G, Sánchez M A, eds. Molecular and Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis. Austin: R.G. Landes Co. Bioscience Publishers 1996: 203-221.
25. Kelso A, Groves P, Ramm L, Doyle A G. Single-cell analysis by RT-PCR reveals differential expression of multiple type 1 and 2 cytokine genes among cells within polarized CD+ T cell populations. Int Immunol 1999: 11: 617-621.